Pierre Fabre Laboratories

Senior AI Scientist- Molecular Discovery- CDI- F/M

Pierre Fabre Laboratories  •  Toulouse, FR (Onsite)  •  3 months ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Who we are ?

Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world, the 2nd largest private French pharmaceutical group and the market leader in France for products sold over the counter in pharmacies.

Its portfolio includes several medical franchises and international brands including Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, Naturactive, Pierre Fabre Oral Care.


Established in the Occitanie region since its creation, and manufacturing over 95% of its products in France, the Group employs some 10,000 people worldwide. Its products are distributed in about 130 countries. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.


In 2019, Ecocert Environment assessed the Group’s corporate social and environmental responsibility approach in accordance with the ISO 26000 sustainable development standard and awarded it the “Excellence” level.


Pierre Fabre is recognized as one of the "World's Best Employers 2021" by Forbes. Our group is ranked in the Top 3 in the cosmetics industry and in the Top 10 in the pharmaceutical industry worldwide.

Your mission

We are seeking a Senior AI Scientist- Molecular Discovery, to design, build, and maintain generative AI workflows and data-driven protocols to support our drug discovery programs.

The successful candidate plays a pivotal role in accelerating the identification of high-quality drug candidates by leading the development of machine learning methodologies to chemical space exploration and molecular optimization within our oncology pipeline.

Your role within a pioneering company in full expansion:

· AI-Driven Discovery Architecture: Designing and implementing robust, automated pipelines that combine AI-driven methods with physics-based simulations.

· AI-Physics Integration & Structural Modeling: Bridge the gap between machine learning and molecular physics by developing workflows for the accurate structure prediction of biomolecular interactions. This involves implementing state-of-the-art diffusion models to characterize the interactions between proteins, nucleic acids, and small molecules.

· AI-Driven Conformational Sampling: Implement and refine AI-based protocols for sampling protein-ligand conformations. This includes utilizing deep learning methods to accelerate or replace traditional molecular dynamics, enabling the rapid exploration of the conformational landscape with high fidelity.

· Methodological Innovation: Evaluating and incorporating emerging methods from peer-reviewed literature to enhance the accuracy and efficiency of the discovery platform.

· Protocol Automation: Developing production-grade Python scripts and libraries to automate routine computational tasks, ensuring reproducibility across all discovery programs.

· Cross-Functional Technical Support: Acting as a technical bridge between medicinal chemistry and data science, ensuring that automated protocols are effectively applied by the computational chemistry team.

This position is based in Toulouse (Oncopole, Langlade site) compatible with teleworking up to 2 days a week according to company rules.

We offer an attractive remuneration/benefits package: Incentives, profit-sharing, Pierre Fabre shareholding with matching contribution, health and provident insurance, 16 days of holidays (RTT) in addition to 25 days of personal holidays, public transport participation, very attractive CE...

Who you are ?

Your skills at the service of innovative projects:

· Education: A PhD in Computer Science, Artificial Intelligence, Cheminformatics, or a related Computational Science. Candidates from a CS/DS background should demonstrate a significant track record of applying these techniques to molecular systems or drug design.

· Machine Learning Expertise: Proven proficiency in designing or deploying deep learning architectures, specifically diffusion models, Graph Neural Networks (GNNs), or Attention-based models, applied to structural biology or chemistry.

· Physics-Aware AI: Experience with the integration of physical principles into ML models, including knowledge of AI-driven structural prediction and techniques for sampling biomolecular ensembles.

· Advanced Programming: Expert-level command of Python and its scientific/AI ecosystem (PyTorch, PyTorch Geometric, RDKit, NumPy, SciPy) for the development of complex discovery workflows.

· Chemistry & Drug Design Awareness: A strong understanding of chemical informatics and the ability to integrate physical constraints, such as synthetic accessibility or valency, into machine learning frameworks.

· Software Engineering: Strong experience in Unix/Linux environments, high-performance computing (HPC) management, and professional version control practices (Git).

· Communication: Excellent written and oral communication skills, with the ability to document technical protocols clearly for a multi-disciplinary audience.

We are convinced that diversity is a source of fulfillment, social balance and complementarity for our employees, which is why our offers are open to all, without restriction.

Pierre Fabre Laboratories

About Pierre Fabre Laboratories

Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.

This makes Pierre Fabre Group :

💊 A pharmaceutical group with a strong positioning : medical and natural

🥈 The second largest dermo-cosmetics laboratory in the world

🥈 The second largest private French pharmaceutical group

🥇 The market leader in France for products sold over the counter in pharmacies.

Our portfolio includes several medical franchises and international brands including ;

Pharmaceutical Care

Pierre Fabre Oncologie

Pierre Fabre Dermatologie

Naturactive

Eau Thermale Avène

Klorane

Ducray

René Furterer

A-Derma

Pierre Fabre Oral Care

Glytone (US)

Darrow (Brasil)

Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.

Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business.

Pierre Fabre Group has a unique company structure.

86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.

In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.

Industry
Chemicals & Materials
Company Size
5,001-10,000 employees
Headquarters
Toulouse, FR
Year Founded
1962
Social Media